Bandingkan Harga & Kinerja Kertas Basuki Rachmat Indonesia Tbk. (KBRI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kertas Basuki Rachmat Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Kertas Basuki Rachmat Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 434,4 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kertas Basuki Rachmat Indonesia Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KBRI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 434,4 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kertas Basuki Rachmat Indonesia Tbk.
PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.
Selengkapnya di halaman KBRI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
